ULGIX LAXI (Docusate sodium 50 mg)

Type: Drug
Pharmaceutical form: Capsules
Package: 30 capsules

Active principle
1 capsule contains:
Docusate sodium (Natrii docusas) 50 mg

Indications:
constipation prevention and chronic constipation treatment, as an adjuvant in patients with haemorrhoids and/or rectal fissures, and in patients whose health condition is a contraindication for intensive straining when opening bowels, preparation for diagnostic and surgical procedures.

Contraindications:  
Hypersensitivity to any ingredient of the product,

nausea and vomiting,

appendicitis,

intestinal obstruction and conditions leading to intestinal obstruction (stool accumulation, enteritis, intestinal stenosis, peritoneal adhesions, hernia, polyps, cysts)

acute abdominal pain of unknown aetiology,

gastrointestinal bleeding of unknown aetiology,

dehydration.